NCCN Guidelines® Insights: Head and Neck Cancers, Version 1.2022.

doi:10.6004/jnccn.2022.0016

Paper

NCCN Guidelines® Insights: Head and Neck Cancers, Version 1.2022.

Published Mar 1, 2022 · J. Caudell, M. Gillison, E. Maghami

Journal of the National Comprehensive Cancer Network : JNCCN

469

Citations

12

Influential Citations

PDF

Abstract

The NCCN Guidelines for Head and Neck Cancers address tumors arising in the oral cavity (including mucosal lip), pharynx, larynx, and paranasal sinuses. Occult primary cancer, salivary gland cancer, and mucosal melanoma (MM) are also addressed. The specific site of disease, stage, and pathologic findings guide treatment (eg, the appropriate surgical procedure, radiation targets, dose and fractionation of radiation, indications for systemic therapy). The NCCN Head and Neck Cancers Panel meets at least annually to review comments from reviewers within their institutions, examine relevant new data from publications and abstracts, and reevaluate and update their recommendations. These NCCN Guidelines Insights summarize the panel's most recent recommendations regarding management of HPV-positive oropharynx cancer and ongoing research in this area.

Highly Cited

Study Snapshot

The NCCN Guidelines Insights for HPV-positive oropharynx cancer recommend individualized treatment plans based on the specific cancer, stage, and pathologic findings.

PopulationOlder adults (50-71 years)

Sample size24

MethodsObservational

OutcomesBody Mass Index projections

ResultsSocial networks mitigate obesity in older groups.

NCCN Guidelines® Insights: Head and Neck Cancers, Version 1.2022.

References

Citations